Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delt

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548537, 548560, 548561, 548562, C07D207327, C07D207333, C07D207335

Patent

active

061214612

ABSTRACT:
A novel crystalline form of [(R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl) -3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form III is characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation and pharmaceutical composition of the same, which is useful as an agent for treating hyperlipidemia and hypercholesterolemia.

REFERENCES:
patent: 5316765 (1994-05-01), Folkers et al.
Tetrahedron Letters, vol. 33, No. 17, 1992, pp. 2283-2284, Baumann, et al.
Pharmaceutical Research, vol. 10, No. 10, 1993, pp. 1461-1465, Kearney, et al.
Atherosclerosis, vol. 111, 1994, pp. 127-142, Bocan, et al.
Tetrahedron Letters, vol.33, No. 17, 1992, pp 2283-2284, Baumann, et al.
Pharmaceutical Research, vol. 10, No. 10, 1993, pp 1461-1465, Kearney, et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delt does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delt will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1074650

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.